Abstract:Reactive oxygen species (ROS) as well-known endogenous stimuli has been widely used to activate drug delivery systems (DDSs) for tumor-specific therapy. Unfortunately, endogenous ROS in the tumor microenvironment (TME) is not enough to achieve effective therapeutic efficacy and cancer cells have adapted to high oxidative stress by upregulating glutathione (GSH) level. Herein, we devised a novel ROS-activable self-immolative prodrug CASDB with both GSH-depletion ability and ROS self-supply competence. Then, an stimuli-responsive nanoplatform integrating CASDB with clinical chemotherapeutics mitoxantrone (MTO) and PLGA was fabricated (denoted as CMPs) through nanoprecipitation method. The CMPs could achieve desired accumulation at tumor tissues through enhanced permeability and retention (EPR) effects. Then the accumulated CMPs could induce tumor cell apoptosis efficiently. Especially, ROS in tumor sites could trigger the immolation of CASDB to generate CA and quinone methide (QM). Then CA and QM cooperatively promoted damage of mitochondria due to oxidative stress and led to cancer cells more sensitive to MTO. Accordingly, MTO could perturb cellular microenvironment of cancer cells then promote the degradation of CASDB. The experiment results demonstrated that CMPs were ideal for desirable synergetic tumor-specific anticancer therapy with negligible systemic toxicity. The half-maximal inhibitory concentrations (IC50) value of CMPs was 6.53 μM, while the IC50 values of MTO was 14.76 μM. And the CMPs group showed the strongest tumor suppressor effect with the tumor sizes increased to 1.2-fold (Control group: 20.6-fold, MTO only: 3.0-fold). This study should be inspirational for designing efficient prodrugs to overcome the handicaps of traditional chemotherapy.

O2-(6-Oxocyclohex-1-en-1-yl)methyl Diazen-1-ium-1,2-diolates: a New Class of Nitric Oxide Donors Activatable by GSH/GST with Both Anti-Proliferative and Anti-Metastatic Activities Against Melanoma (vol 53, Pg 5059, 2017)

Correction: O2-(6-Oxocyclohex-1-en-1-yl)methyl Diazen-1-ium-1,2-diolates: a New Class of Nitric Oxide Donors Activatable by GSH/GSTπ with Both Anti-Proliferative and Anti-Metastatic Activities Against Melanoma.

<i>O</i><sup>2</sup>-(6-Oxocyclohex-1-en-1-yl)methyl diazen-1-ium-1,2-diolates: a new class of nitric oxide donors activatable by GSH/GSTπ with both anti-proliferative and anti-metastatic activities against melanoma

Design, Synthesis, and Evaluation of Diazeniumdiolate-Based DNA Cross-Linking Agents Activatable by Glutathione S-Transferase.

Hybrid Molecule from O2-(2,4-Dinitrophenyl)diazeniumdiolate and Oleanolic Acid: A Glutathione S-Transferase Π-Activated Nitric Oxide Prodrug with Selective Anti-Human Hepatocellular Carcinoma Activity and Improved Stability

O2-(2,4-dinitrophenyl)diazeniumdiolates Derivatives: Design, Synthesis, Cytotoxic Evaluation and Reversing MDR in MCF-7/ADR Cells.

Design and Synthesis of New Hybrids from 2-Cyano-3,12-dioxooleana- 9-Dien-28-oic Acid and O2-(2,4-dinitrophenyl) Diazeniumdiolate for Intervention of Drug-Resistant Lung Cancer.

Synthesis and Evaluation of O2‑Derived Diazeniumdiolates Activatable via Bioorthogonal Chemistry Reactions in Living Cells

Glutathione S-Transferase Π-Activatable O2-(Sulfonylethyl Derived) Diazeniumdiolates Potently Suppress Melanoma in Vitro and in Vivo.

Synthesis and anti-tumor activity of glycosyl oxadiazoles derivatives.

Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy

Sphorodiamidate Mustard-Based O 2-Phosphorylated Diazeniumdiolates with Potent Anticancer Activity †

Synthesis and Antitumor Activity of Nitric Oxide-Donating Glycyrrhetinic Acid Derivatives Coupled with Nitrate Moiety

Peroxidase-like Active Nanomedicine with Dual Glutathione Depletion Property to Restore Oxaliplatin Chemosensitivity and Promote Programmed Cell Death

Novel Anticancer Oridonin Derivatives Possessing a Diazen-1-ium-1,2-diolate Nitric Oxide Donor Moiety: Design, Synthesis, Biological Evaluation and Nitric Oxide Release Studies.

Incorporation of nitric oxide donor into 1,3-dioxyxanthones leads to synergistic anticancer activity.

GSH‐Responsive Organosilica Hybrid Nanosystem as A Cascade Promoter for Enhanced Starvation and Chemodynamic Therapy

ROS and GSH-responsive S-nitrosoglutathione Functionalized Polymeric Nanoparticles to Overcome Multidrug Resistance in Cancer.

<i>O</i><SUP>2</SUP>-3-Aminopropyl diazeniumdiolates suppress the progression of highly metastatic triple-negative breast cancer by inhibition of microvesicle formation <i>via</i> nitric oxide-based epigenetic regulation (vol 9, pg 6893, 2018)

A double-gain theranostic nanoplatform based on self-supplying H 2 O 2 nanocomposites for synergistic chemodynamic/gas therapy

A Novel ROS-activable Self-Immolative Prodrug for Tumor-Specific Amplification of Oxidative Stress and Enhancing Chemotherapy of Mitoxantrone.